DEITSCH RIK J 4
4 · NUTRA PHARMA CORP · Filed Jun 26, 2018
Insider Transaction Report
Form 4
DEITSCH RIK J
DirectorPresident, CEO10% Owner
Transactions
- Purchase
Nutra Pharma Corp Common Stock
2016-12-19$0.01/sh+15,000,000$75,000→ 43,298,859 total - Purchase
Nutra Pharma Corp Common Stock
2014-04-10$0.08/sh+1,250,000$100,000→ 4,791,959 total - Award
Nutra Pharma Corp Common Stock
2014-12-11$0.24/sh+506,900$121,656→ 5,298,859 total - Award
Nutra Pharma Corp Common Stock
2015-06-13$0.18/sh+4,000,000$740,000→ 9,298,859 total - Purchase
Nutra Pharma Corp Common Stock
2016-07-05$0.01/sh+15,000,000$100,500→ 28,298,859 total - Award
Nutra Pharma Corp Common Stock
2016-06-28$0.01/sh+4,000,000$54,000→ 13,298,859 total - Award
Nutra Pharma Series A Preferred
2017-10-30$0.13/sh+3,000,000$399,000→ 3,000,000 total→ Series A Preferred (3,000,000 underlying)
Footnotes (1)
- [F1]Preferred shares have no right of conversion and are valued at $0.133 per share, which represents the actual cost paid. The Series A Preferred Stock will vote with the Corporation's common stock as a single class on all matters or consents for the Corporation's common stockholders. Each share of Series A Preferred Stock is entitled to one thousand votes per share.